The Chemours Co 2025年季度报告

FORM10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period endedMarch 31,2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number001-36794 The Chemours Company(Exact Name of Registrant as Specified in Its Charter) 46-4845564(I.R.S. EmployerIdentification No.) 1007 Market Street,Wilmington,Delaware19801(Address of Principal Executive Offices) (302)773-1000(Registrant’s Telephone Number) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of RegulationS-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerginggrowth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2of the Exchange Act. Accelerated Filer☐Smaller reporting company☐Emerging growth company☐ Large Accelerated Filer☒Non-Accelerated Filer☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ The registrant had149,674,209shares of common stock, $0.01 par value, outstanding at May 1, 2025. The Chemours Company TABLE OF CONTENTS Part IFinancial InformationItem 1.Interim Consolidated Financial StatementsInterim Consolidated Statements of Operations (Unaudited)Interim Consolidated Statements of Comprehensive Income (Unaudited)Interim Consolidated Balance Sheets (Unaudited)Interim Consolidated Statements of Stockholders’ Equity (Unaudited)Interim Consolidated Statements of Cash Flows (Unaudited)Notes to the Interim Consolidated Financial Statements (Unaudited)Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations64Item 3.Quantitative and Qualitative Disclosures About Market Risk87Item 4.Controls and Procedures88 The Chemours CompanyInterim Consolidated Statements of Operations (Unaudited)(Dollars in millions, except per share amounts) See accompanying notes to the interim consolidated financial statements. See accompanying notes to the interim consolidated financial statements. The Chemours CompanyInterim Consolidated Balance Sheets (Unaudited)(Dollars in millions, except per share amounts) See accompanying notes to the interim consolidated financial statements. The Chemours CompanyInterim Consolidated Statements of Cash Flows (Unaudited)(Dollars in millions) The Chemours CompanyNotes to the Interim Consolidated Financial Statements (Unaudited)(Dollars in millions, except per share amounts) Note1. Background, Description of the Business, and Basis of Presentation The Chemours Company (“Chemours”, or the “Company”) is a leading, global provider of performance chemicals thatare key inputs in end-products and processes in a variety of industries. The Company delivers customized solutionswith a wide range of industrial and specialty chemical products for markets, including coatings, plastics, refrigerationand air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. TheCompany’s principal products include refrigerants, titanium dioxide (“TiO2”) pigment and industrial fluoropolymer resins.Chemours manages and reports its operating results through itsthree principal reportable segments: Thermal &Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & SpecializedSolutions segment is a leading, global provider of refrigerants, thermal management solutions, propellants, blowingagents, and specialty solvents. The Titanium Technologies segment is a leading, global provider of TiO2pigment, apremium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency and protection across avariety of applications. The Advanced Performance Materials segment is a leading, global provider of high-endpolymers and advanced materials that deliver unique attributes, including low friction coefficients, extreme te